Momenta Pharmaceuticals, Inc. (MNTA)

[rwwine]

At $262M, I estimate $80.3 M mL revenue, operating expenses of $24.2M (including an R&D adjustment that Rick Shea mentioned would impact income/revenue for Q2-2011), shares outstanding of 50.7 M with a resulting earnings of $1.11.